Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
[AIDS 2026] aidsmap: Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges
1+ hour, 14+ min ago (178+ words) European AIDS Treatment Group [AIDS 2026] aidsmap: Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges Lenacapavir – the highly effective HIV prevention medication that only requires two shots a year – is currently rolling out across African countries with a…...
[AIDS 2026] aidsmap: Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing
1+ hour, 18+ min ago (248+ words) European AIDS Treatment Group [AIDS 2026] aidsmap: Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing Merck’s investigational once-monthly PrEP pill could be manufactured and sold profitably for around $3 per person…...
[AIDS 2026] [Report] KFF/UNAIDS: Donor government funding for HIV drops by $2.1 billion in 2025
1+ day, 19+ hour ago (186+ words) European AIDS Treatment Group [AIDS 2026] [Report] KFF/UNAIDS: Donor government funding for HIV drops by $2.1 billion in 2025 due to declines in funding from the United States, marking largest annual decrease since scale-up for the HIV response began Donor government funding…...
[AIDS 2026] [Press release] ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
1+ day, 19+ hour ago (297+ words) European AIDS Treatment Group [AIDS 2026] [Press release] ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV London, 27 July 2026 – ViiV Healthcare, the global specialist HIV company majority owned…...
The Silver Zone: A Networking Zone for Older People Living with HIV at AIDS 2026
2+ day, 11+ hour ago (245+ words) We are proud to announce the return of The Silver Zone to the IAS Global Village at AIDS2026 — a dedicated space created for older people living with HIV to connect, be celebrated, and be heard. Whether you’re living with HIV, ageing…...
Health Policy Watch: African Union pushes for greater domestic spending on health amid reports of huge disruptions to HIV and TB services
2+ day, 23+ hour ago (140+ words) The African Union (AU) held a special health summit on 21-22 July, primarily aimed at mobilising high-level political support for more domestic health spending – particularly on HIV, TB and maternal health. The summit coincided with the release of two new studies…...
[AIDS 2026] [Press statement] Activists disrupt US Global AIDS Coordinator Jeff Graham at International AIDS Conference
3+ day, 7+ hour ago (159+ words) Activists disrupt US Global AIDS Coordinator Jeff Graham at International AIDS Conference, protesting Trump’s chokehold on congressionally appropriated HIV funding, mass closure of key population programs, and attacks on transparent oversight of PEPFAR programs New data show Trump and Rubio…...
[AIDS 2026] [Press release] Merck announces initial access plans for alimatravir, an investigational once-monthly oral HIV PrEP in Phase 3 development
3+ day, 8+ hour ago (273+ words) European AIDS Treatment Group [AIDS 2026] [Press release] Merck announces initial access plans for alimatravir, an investigational once-monthly oral HIV PrEP in Phase 3 development Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced early components of…...
EATG at AIDS 2026
5+ day, 9+ hour ago (229+ words) EATG is happy to take part in the 26th International AIDS Conference (AIDS 2026) with four posters and as a co-organiser of the Silver Zone in the Global Village. Whether you are joining in Rio de Janeiro or online, we invite you…...
Unitaid invests an additional US$15 million to accelerate introduction, adoption and uptake of breakthrough HIV prevention products in diverse regions
5+ day, 21+ hour ago (258+ words) European AIDS Treatment Group Unitaid invests an additional US$15 million to accelerate introduction, adoption and uptake of breakthrough HIV prevention products in diverse regions Building on its broader US$110 million investment in next-generation HIV prevention, Unitaid announced an additional US…...